Omar Alkharabsheh/LinkedIn
Aug 21, 2026, 10:33
Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
Omar Alkharabsheh, Medical Director at Orlando Health shared a post on LinkedIn:
”I’m excited to share that I’ve recently moved to Orlando and joined Orlando Health Cancer Institute as the Medical Director of the Hematology Center of Excellence.
I took this exciting opportunity to build and expand the hematologic malignancies program, with a vision to bring innovative therapies and cutting-edge clinical research to patients in central Florida. I look forward to working with an exceptional multidisciplinary team to advance the care of patients, expand access to clinical trials, and help take the program to new levels of excellence.”
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator